FRAMINGHAM, Mass., May 5, 2016 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that President and Chief Executive Officer Doug Godshall is scheduled to present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 10, 2016 at 4:20 p.m. PT (7:20 p.m. ET).  The conference is being held May 10-12 in Las Vegas.

A live webcast of the company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days after the presentation.

About HeartWare International
HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat patients around the world suffering from advanced heart failure.  Dedicated to developing new, minimally invasive technologies to revolutionize the treatment of patients with end-stage heart failure, HeartWare has multiple technologies in development to offer progressively less-invasive mechanical circulatory support options.  HeartWare's corporate headquarters are located in Framingham, Massachusetts, and the company has technology, operations, manufacturing and distribution centers in Miami Lakes, Florida; Arden Hills, Minnesota; and Hannover, Germany.  For additional information about the company, please visit www.heartware.com.

HEARTWARE, HVAD, MVAD, PAL, SYNERGY, CIRCULITE and HeartWare logos are trademarks of HeartWare, Inc. or its affiliates.  

For additional information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartware.com 
Phone: +1 508 739 0864

Logo - http://photos.prnewswire.com/prnh/20150901/262901LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heartware-presentation-at-the-bank-of-america-merrill-lynch-2016-health-care-conference-to-be-webcast-300264013.html

SOURCE HeartWare International, Inc.